Notified Bodies Must Be Involved In EU Joint HTA Discussions, Urges BSI Clinical Compliance Lead
Executive Summary
The EU Regulation on HTA will see some medtech manufacturers offered scientific advice on planned clinical investigations. According to BSI’s global head of clinical compliance, MDR/IVDR notified bodies can offer valuable expertise and must not be left out of these discussions.